NHS Unveils ‘Super-Jab,’ Claims It Can Treat 15 Cancer Types

The National Health Service (NHS) has rolled out a new ‘super-jab’ that thousands of patients will receive monthly.

NHS claims the ‘super-jab’ can treat 15 types of cancer.

“Thousands of patients will benefit from a new cancer jab for more than a dozen types of the disease, with the NHS the first in Europe to offer the new injection,” NHS stated.

“The health service is rolling out an injectable form of immunotherapy, nivolumab, which means patients can receive their fortnightly or monthly treatment in 5 minutes instead of up to an hour via an IV drip,” it added.

Thousands of patients in England are set to benefit from a new five-minute ‘super-jab’ that can treat 15 types of cancer that will ‘transform lives’. The NHS is the first health service in Europe to offer the injection, which will save around a year’s worth of treatment,… pic.twitter.com/tvrU5kzgXr

— “Sudden And Unexpected” (@toobaffled) May 2, 2025

Per NHS:

The roll-out will save over a year’s worth of treatment time for patients and NHS teams annually – enabling patients to spend less time in hospital while freeing up staff capacity to deliver more appointments and treatments.

The new jab can be used to treat 15 cancer types, including skin cancer, bladder, and oesophagus, and it is estimated around 1,200 patients in England per month could benefit.

This follows approval from the UK’s medicines regulator, the Medicines and Healthcare products Regulatory Agency (MHRA) today.

In clinical trials, patients were highly satisfied with the under-the-skin injection, which takes 3-5 minutes to administer, and preferred it to the IV form of the drug which takes 30 to 60 minutes every 2 weeks or four weeks, depending on the cancer type.

Around 2 in 5 patients who currently receive IV nivolumab, which is one of the most widely used cancer treatments, should be eligible for the new jab.

NHS staff administering the jab could save around 1,000 hours of treatment time for patients and clinicians every month – the equivalent of more than 1 full year of time annually.

Most eligible new patients are also expected to begin on the injectable form of nivolumab.

NHS cancer services will now be preparing to treat the first patients with the new treatment next month when supplies of the product are received in the UK, helping to free up valuable resources in nursing and pharmacy teams, as well as helping with capacity demands in cancer day units, where the drug is currently administered.

This is the latest in a series of NHS cancer treatment innovations introduced to save patients time and improve access, including the rollout of new injections for breast cancer, multiple sclerosis, and blood disorders.

The NHS is introducing a new five-minute injection for 15 types of cancer, including skin, bladder and oesophageal.

NHS staff administering the jab could save around 1,000 hours of treatment time for patients and clinicians every month.

https://t.co/gMCtLD3vrZ pic.twitter.com/6iUazTT1jF

— NHS England (@NHSEngland) April 30, 2025

WATCH:

The United Kingdom’s National Health Service, the NHS, has rolled out a super jab that can treat up to 15 types of cancers, drastically cutting down treatment time from an hour to just 5 minutes@MollyGambhir reports pic.twitter.com/k3Bwvzjb9Q

— WION (@WIONews) May 1, 2025

Daily Mail reports:

It comes amid a disturbing rise in cancers including skin and bowel in the under 50s, which has baffled doctors around the globe.

Professor Peter Johnson, NHS England National Clinical Director for Cancer, said: ‘Immunotherapy has already been a huge step forward for many NHS patients with cancer, and being able to offer it as an injection in minutes means we can make the process far more convenient.

‘This treatment is used for 15 different types of the disease, so it will free up thousands of valuable clinicians’ time every year, allowing teams to treat even more patients and helping hospital capacity.

‘And this is just the latest development in the NHS’s ongoing commitment to provide patients with the latest cancer therapies and treatment options that truly transform lives.’

Ashley Dalton, the public health minister who announced earlier this year that she had been diagnosed with breast cancer for a second time, added: ‘Britain is a hotbed of innovation, masterminding the newest tech and medical inventions to help people navigating illness.

‘A new jab that fastens up cancer treatment is a prime example of this, so it’s fantastic to see cancer patients in England will be among the first in Europe to benefit.

MAY I HUMBLY SUGGEST DOING THIS INSTEAD?

Dr. McCullough Reveals the Cancer-Fighting Drug Big Pharma Doesn’t Want You to Know About

Dr. McCullough Reveals the Cancer-Fighting Drug Big Pharma Doesn’t Want You to Know About

The COVID-19 pandemic, and the ensuing response by the medical establishment, was an eye-opening experience for tens of millions of Americans. We watched as the medical establishment put the biopharmaceutical complex’s bottom line above the health and well-being of the American people.

Sadly, greed in medicine isn’t new and it isn’t restricted just to pandemic responses. Indeed, greed is often the primary motivation for much of our medical establishment’s response to almost every single healthcare challenge we face.

This is certainly the case when it comes to the fight against cancer:

A recent study in the journal Cancer takes a closer look at the impact of cancer drug prices on pharma revenues. Dr. Daniel Meyers at the University of Calgary and colleagues looked at the total revenue generated by ten large pharmaceutical companies from 2010 to 2019, and compared the revenue from cancer and non-cancer drugs.

They found that sales from cancer drugs are becoming an increasingly important part of pharmaceutical companies’ revenue. While the annual revenue generated by cancer drugs increased by 70% from 2010 to 2019, the revenue from non-cancer drugs decreased by 18%. In 2010, 14% of total revenue from these ten companies was from cancer drugs; in 2019, cancer drugs made up one quarter of revenue.

Even worse, there is little correlation between the amount of money charged for these drugs and treatments and health outcomes:

If we were getting vastly improved clinical outcomes for these expensive drugs, they might be worth the price. But in the US, the cost of cancer drugs is not correlated with clinical benefit, according to a study in The Lancet Oncology. And once the price of a drug goes above $100,000, it doesn’t matter how good the drug is — when people can’t afford it, they won’t take it.

It should come as no surprise then, that big pharma and the medical establishment have absolutely no interest in pursuing low-cost treatments.

Fortunately, medical professionals like Dr. Peter McCullough are committed to delivering healthcare solutions that are safe, effective AND affordable. This is exactly why Dr. McCullough and his team are digging in to the potential for ivermectin in combatting cancers.

According to a new study, the early returns are promising. According to the McCullough Foundation:

The study titled “A Review of Ivermectin Use in Cancer Patients: Is it Time to Repurpose the Ivermectin in Cancer Treatment?” was just published in the journal Acta Poloniae Pharmaceutica – Drug Research…

Based on the most comprehensive systematic review of ivermectin use in cancer patients to date, ivermectin appears to be safe—even in individuals undergoing active chemotherapy. Its broad range of anticancer mechanisms demonstrated in preclinical models, combined with anecdotal reports of cancer-related improvements, support its candidacy for repurposing as an oncologic therapy. Well-designed, large-scale clinical trials should be launched as soon as possible to properly assess ivermectin’s potential against cancer.

Indeed, ivermectin in concert with mebendazole has shown even more promise in treating a wide variety of cancers.

Mebendazole, an anti-parasitic like ivermectin, has been prescribed for 100 years to help eradicate parasites – which over 60 million Americans have inside their body today, according to the CDC.

Safe, Effective and Affordable!

If you feel off, a parasite cleanse may help you regain your health. There is no better cleanse than pure lab-tested Ivermectin + Mebendazole, compounded into a single capsule by The Wellness Company.

• Ivermectin and Mebendazole combine to effectively treat parasitic infections.

• 90 Oral Capsules, each containing 25mg Ivermectin + 250mg Mebendazole, a clinically effective dose.

• The Gold Standardof safety and efficacy; the only medication of its kind prescribed by a licensed doctor and compounded by a 50-state licensed pharmacy.

Medication You Can Trust from a Trusted Source in the USA

The medical experts at The Wellness Company – like Dr. Peter McCullough and Dr. Kelly Victory – were leaders in the efforts to provide the public with accurate medical information during COVID. These experts have repeatedly shown that they prioritized the health and welfare of their patients over the bottom line of the big pharmaceutical companies.

Now, The Wellness Company is the only company in the world to prescribe pure compounded Ivermectin + Mebendazole from a 50-state licensed pharmacy, in a high-dose 90-day supply.

The Wellness Company’s Ivermectin + Mebendazole Parasite Cleanse is in extreme demand, selling out 3 times – prompting The Wellness Company to build a stockpile of medication to serve customers through any potential supply chain disruptions.

With the threat of tariffs restricting international trade, many people have turned to shady overseas sources of medication or unlicensed pharmacies. The Wellness Company proudly remains the only legitimate producer of this compounded formula in the US.

Head over to The Wellness Company today to order a 90-day supply of the ultimate parasite cleanse – Ivermectin + Mebendazole. Simply fill out the 2-minute intake questionnaire after checkout to complete your prescription request.

What people are saying about The Wellness Company’s Ivermectin + Mebendazole:

I am grateful to have a medicine as potentially beneficial as ivermectin and mebendazole, but the most important thing for me is the faith I have in Dr. McCullough and The Wellness Company for making a safe product, in our country. I am grateful for them protecting us through the use of proven products and the peace in knowing that I’m taking something that is precisely what it states on the labels. – Jennifer W.

My daughter was diagnosed with uterine cancer and lung nodules that turned out to be cancerous. She started taking ivermectin/mebendazole 2 weeks ago. She had a PET scan last month and her lungs were littered with dime and pea sized nodules from the top to the bottom of her lungs. She had a biopsy on the 14th of April and the Physcian had to SEARCH for a nodule big enough to get a sample from, and the ONE that he found was at the bottom of her left lung that he said was only a few centimeters wide…. Thank All of you Doctors on this site for giving us HOPE and HEALING!!! – Helen

Click here to see if Ivermectin and Mebendazole from The Wellness Company is right for you.

(Note: The information provided is intended for generalized informational purposes only and should not be considered personal medical advice or used as a substitute for professional healthcare guidance. It is your responsibility to comply with all applicable laws, regulations, and guidelines regarding the purchase, possession, and use of prescription medications. Thank you for supporting businesses like the one presenting a sponsored message in this article and ordering through the links provided, which benefits WLTReport. We appreciate your support and the opportunity to keep you SAFE and HEALTY!)

What do you think?